X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (77) 77
humans (74) 74
aminoglycosides (42) 42
anti-bacterial agents - administration & dosage (37) 37
drug administration schedule (36) 36
once-daily tobramycin (35) 35
pharmacokinetics (35) 35
male (33) 33
tobramycin (33) 33
female (32) 32
pharmacology & pharmacy (32) 32
adult (28) 28
cystic fibrosis (28) 28
gentamicin (28) 28
efficacy (26) 26
anti-bacterial agents - pharmacokinetics (25) 25
adolescent (21) 21
amikacin (21) 21
child (21) 21
anti-bacterial agents - therapeutic use (20) 20
antibiotics (20) 20
anti-bacterial agents - adverse effects (19) 19
pseudomonas-aeruginosa (19) 19
cystic fibrosis - complications (18) 18
nephrotoxicity (18) 18
infectious diseases (17) 17
medicine, general & internal (17) 17
once-daily dosing (17) 17
tobramycin - administration & dosage (17) 17
infections (16) 16
aminoglycosides - administration & dosage (15) 15
bacterial infections - drug therapy (15) 15
pediatrics (15) 15
therapy (15) 15
toxicity (15) 15
cystic fibrosis - drug therapy (14) 14
drug therapy (14) 14
middle aged (14) 14
aminoglycosides - adverse effects (13) 13
once-daily aminoglycoside (13) 13
pseudomonas aeruginosa (13) 13
pseudomonas infections - drug therapy (13) 13
single (13) 13
acute respiratory exacerbations (12) 12
aminoglycoside (12) 12
injections, intravenous (12) 12
metaanalysis (12) 12
respiratory system (12) 12
drug monitoring (11) 11
microbial sensitivity tests (11) 11
aged (10) 10
aminoglycosides - therapeutic use (10) 10
children (10) 10
infusions, intravenous (10) 10
microbiology (10) 10
netilmicin (10) 10
pulmonary exacerbations (10) 10
tobramycin - pharmacokinetics (10) 10
treatment outcome (10) 10
adult patients (9) 9
animals (9) 9
anti-bacterial agents - blood (9) 9
anti-bacterial agents - pharmacology (9) 9
ceftazidime (9) 9
child, preschool (9) 9
cystic-fibrosis (9) 9
gentamicins - administration & dosage (9) 9
aminoglycoside therapy (8) 8
dosage and administration (8) 8
dose-response relationship, drug (8) 8
drug dosages (8) 8
in-vitro (8) 8
infant (8) 8
patients (8) 8
pharmacodynamics (8) 8
pharmacology (8) 8
retrospective studies (8) 8
tobramycin - therapeutic use (8) 8
abridged index medicus (7) 7
acute pulmonary exacerbations (7) 7
aged, 80 and over (7) 7
aminoglycosides - pharmacokinetics (7) 7
care and treatment (7) 7
respiratory tract infections - drug therapy (7) 7
risk-factors (7) 7
young adult (7) 7
adaptive resistance (6) 6
adults (6) 6
amikacin - administration & dosage (6) 6
amikacin - pharmacokinetics (6) 6
aminoglycosides - pharmacology (6) 6
antibacterial agents (6) 6
double-blind (6) 6
drug therapy, combination (6) 6
febrile neutropenic patients (6) 6
kidney diseases - chemically induced (6) 6
once daily (6) 6
once daily dosing (6) 6
population pharmacokinetics (6) 6
prospective studies (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 02/2005, Volume 365, Issue 9459, pp. 573 - 578
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 2018, Volume 58, Issue 3, pp. 389 - 399
Objectives The objective of this article is to investigate the influence of blood sampling times on tobramycin exposure estimation and clinical decisions and... 
PHARMACOKINETICS | SUGGESTIONS | RESISTANCE | ONCE-DAILY TOBRAMYCIN | PHARMACOLOGY & PHARMACY | CYSTIC-FIBROSIS | BAYESIAN-ESTIMATION | INTRAVENOUS TOBRAMYCIN | UNDER-THE-CURVE | AMINOGLYCOSIDE THERAPY | Human error | Antibiotics | Human exposure | Cystic fibrosis | Clinical medicine | Patients | Drug dosages | Methods
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 8/2018, Volume 57, Issue 8, pp. 1017 - 1027
Bayesian forecasting (BF) methods for tobramycin dose individualisation has not seen widespread clinical adoption, despite being endorsed by clinical practice... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | THERAPY | POPULATION PHARMACOKINETICS | PERFORMANCE | ONCE-DAILY TOBRAMYCIN | PHARMACOLOGY & PHARMACY | INTRAVENOUS TOBRAMYCIN | REGIMENS | Antibiotics | Cystic fibrosis | Population | Regression analysis | Clinical medicine | Patients | Drug dosages | Bayesian analysis | Children & youth
Journal Article
Journal Article
Pediatric Pulmonology, ISSN 8755-6863, 2001, Volume 31, Issue 5, pp. 367 - 376
Journal Article
SAGE Open Medicine, ISSN 2050-3121, 10/2017, Volume 5, pp. 2050312117736694 - 2050312117736694
Objectives: Previous studies have examined renal safety of once daily intravenous tobramycin in individuals with cystic fibrosis. This has been mainly in... 
Journal Article
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, ISSN 1551-6776, 01/2012, Volume 17, Issue 1, pp. 67 - 77
To assess the ability of an empiric once-daily dosing (ODD) tobramycin regimen to achieve desired serum concentrations in patients with cystic fibrosis (CF);... 
pharmacokinetics | Cystic fibrosis | Clinical Investigations | tobramycin | once-daily
Journal Article
Journal Article
Journal Article
Pediatrics, ISSN 0031-4005, 07/2004, Volume 114, Issue 1, pp. e111 - 118
Background. There has been a long-standing debate regarding whether aminoglycosides should be administered on a multiple daily dosing (MDD) or once-daily... 
toxicity | CEFTAZIDIME PLUS AMIKACIN | TWICE-DAILY AMIKACIN | SINGLE | DAILY GENTAMICIN |